Randomized Study of Preoperative Dexamethasone for Quality of Recovery in VATS Lung Resection Patients — APV  

Lung Cancer Clinical Trial

Official title: Randomized Study of Preoperative Dexamethasone for Quality of Recovery in VATS Lung Resection Patients

Status Completed

Clinical Trial Summary

The proposed study is a randomized, double-blind, placebo-controlled evaluation if a small dose of IV dexamethasone during induction anesthesia in association to pre and postoperative intercostal nerve block, improves quality of recovery of thoracoscopic lung resection patients.

Clinical Trial Description

This is a study composed by 2 groups of 50 patients undergoing VATS for lung cancer. All subjets will receive intraoperative intercostal nerve block with a maximum dose of 2 mg/kg of bupivacaine with epinephrine 1:200.000 at the beginning and at the end of procedure.

The control group will receive a bolus dose of dexamethasone (0.1 mg/kg) and the placebo group saline solution. The study drug or placebo will be administered at the time of anesthetic induction (approximately 30 minutes before surgical incision). Patients will be evaluated daily with the quality of recovery questionary, visual analogue pain and portable spirometry. And, the patients will have pulmonary lung function assessed by portable spirometry. ;

Related Conditions & MeSH terms

• Lung Cancer
• Lung Neoplasms

• NCT number: NCT02275702
• Study type: Interventional
• Source: Laval University
• Status: Completed
• Phase: Phase 4
• Start date: October 2014
• Completion date: December 2016